Institutional shares held 112 Million
179K calls
66.2K puts
Total value of holdings $13.5B
$21.7M calls
$8.01M puts
Market Cap $15.3B
126,224,000 Shares Out.
Institutional ownership 88.49%
# of Institutions 541


Latest Institutional Activity in PKI

Top Purchases

Q3 2024
Gateway Investment Advisers LLC Shares Held: 38.1K ($4.61M)
Q3 2024
Sg Americas Securities, LLC Shares Held: 50K ($6.05M)
Q3 2024
Van Eck Associates Corp Shares Held: 41K ($4.96M)
Q3 2024
Raymond James Financial Services Advisors, Inc. Shares Held: 24.9K ($3.01M)
Q3 2024
International Assets Investment Management, LLC Shares Held: 13.7K ($1.65M)

Top Sells

Q3 2024
Ceredex Value Advisors LLC Shares Held: 791K ($95.7M)
Q3 2024
Assenagon Asset Management S.A. Shares Held: 28K ($3.38M)
Q3 2024
Artemis Investment Management LLP Shares Held: 55.2K ($6.68M)
Q3 2024
Coronation Fund Managers Ltd. Shares Held: 92.8K ($11.2M)
Q3 2024
New York State Common Retirement Fund Shares Held: 74.1K ($8.97M)

About PKI

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.


Insider Transactions at PKI

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
137K Shares
From 16 Insiders
Grant, award, or other acquisition 22.1K shares
Exercise of conversion of derivative security 103K shares
Bona fide gift 12.1K shares
Sell / Disposition
101K Shares
From 13 Insiders
Payment of exercise price or tax liability 22K shares
Bona fide gift 12.6K shares
Open market or private sale 66.4K shares

Track Institutional and Insider Activities on PKI

Follow PERKINELMER INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PKI shares.

Notify only if

Insider Trading

Get notified when an Perkinelmer Inc insider buys or sells PKI shares.

Notify only if

News

Receive news related to PERKINELMER INC

Track Activities on PKI